Bone Marrow Failure Drugs
Feb 23, 2026
Bone Marrow Failure: The Silent Global Crisis Driving a New Era of Therapeutic Innovation
Summary In 2024, the 7MM reported approximately 35,000 incident BMF cases, highlighting the persistent clinical burden and the ongoing need for earlier diagnosis and more effective treatment strategies. ROMIPLATE has made notable regulatory progress in Japan, its only approved market for aplastic anemia, ex...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
